FDA Pediatrics Office Under Murphy Plans To Recruit Review Div. Liaisons
Executive Summary
FDA's Office of Pediatric Drug Development & Special Initiatives hopes to attract an expert from every drug review division to serve as a liaison in assessing pediatric drug applications.
You may also be interested in...
CDER Deputy Galson Will Run Drug Center For At Least Six Months
Center for Drug Evaluation & Research Deputy Director Steve Galson, MD, will be acting center director during the period when FDA is expected to announce a decision on forced Rx-to-OTC switches
FDA Pediatric/Counterterrorism Office Will Announce Division Directors In Fall
FDA's Office of Counterterrorism and Pediatric Drug Development (OCTAP) is expected to announce directors for its separate counterterrorism and pediatric drug divisions in the fall
FDA Pediatric/Counterterrorism Office Will Announce Division Directors In Fall
FDA's Office of Counterterrorism and Pediatric Drug Development (OCTAP) is expected to announce directors for its separate counterterrorism and pediatric drug divisions in the fall